SARS-COV-2 ANALYSIS

SARS-COV-2 ANALYSIS

Equipment & Device Manufacturers

Information

Our customers and the microbiome market at large have expressed interest in research use only method for the study of SARS-CoV-2, the virus that causes COVID-19. Diversigen has updated its viral metagenomics pipeline for the detection of SARS-CoV-2. This pipeline can detect SARS-CoV-2 in confirmed positive samples and it can differentiate between coronavirus species. In addition the pipeline can be used to recover the SARS-CoV-2 genome at a depth and coverage that allows for genome assembly, which is crucial for strain and/or mutation rate tracking. In addition to the commonly used nasal nasopharyngeal samples, there are reports that SARS-CoV-2, can be detected in samples that are often of interest to microbiome researchers, including saliva and feces; the pipeline is compatible with these three samples types, and others. Diversigen has an experienced, dedicated team ready to help you in these challenging times. Connect with our scientific advisors today using the Live Chat feature.
Diversigen / DNA GenotekDiversigen and DNA Genotek Inc. are subsidiaries of OraSure Technologies, Inc. (NASDAQ: OSUR) working as a group to provide high-quality microbial sample collection products and comprehensive services for sample processing, sequencing, and bioinformatic analysis. Diversigen (powered by CoreBiome analytics) offers the best science available to accelerate microbiome and metagenomic discovery for academic, pharmaceutical, therapeutic, agricultural and environmental applications. From study design to sample processing, data generation, and full custom analysis, Diversigen ensures you get the most out of your data. DNA Genotek’s OMNIgene product line immediately stabilizes microbiota samples at the point of collection, ensuring an unbiased ‘snapshot’ of the microbial community. Self-collection kits for stool, oral, skin, vaginal and animal sampling are available. OMNIgene.ORAL (OM-505) is a validated saliva self-collection kit for stabilizing oral nucleic acids (DNA and RNA) for validated SARS-Cov-2 detection assays. OMNIgene.ORAL is also expected to render enveloped viruses (such as SARS-Cov-2) non-infective, suitable for transport. Read more here https://www.dnagenotek.com/US/pdf/MK-01430.pdf

Log in